Abstract
We examined the effects of bone marrow transplantation (BMT) on immune-mediated inner ear diseases in MRL/Mp-lpr/lpr (MRL/lpr) mice, which manifest not only lupus nephritis but also sensorineural hearing loss (SNHL) at the age of 20 weeks. These mice were treated with cyclophosphamide (CY) and irradiation (5 Gy × 2), followed by the transplantation of bones plus bone marrow cells from allogeneic normal C57BL/6 mice at the age of 12 weeks. Hematolymphoid cells were reconstituted with donor-derived cells 3 months after BMT. Thus-treated MRL/lpr mice showed neither lupus nephritis nor SNHL even 24 weeks after BMT. No pathological findings were observed in either glomeruli or cochleae. These findings suggest that BMT can be used to prevent the development of autoimmune SNHL in MRL/lpr mice. Bone Marrow Transplantation (2000) 26, 887–892.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
McCabe BF . Autoimmune sensorineural hearing loss Ann Otol Rhinol Laryngol 1979 88: 585–589
Veldman JE, Roord JJ, O’Connor AF, Shea JJ . Autoimmunity and inner ear disorders: an immune-complex mediated sensorineural hearing loss Laryngoscope 1984 94: 501–507
Harris JP . Experimental autoimmune hearing loss Laryngoscope 1987 97: 63–76
Kanzaki J, Ouchi T . Steroid-responsive bilateral sensorineural hearing loss and immune complexes Arch Otorhinolaryngol 1981 230: 5–9
Hughes GB, Barna BP, Kinney SE et al. Autoimmune endolymphatic hydrops: five-year review Otolaryngol Head Neck Surg 1988 98: 221–225
Bowman CA, Linthicum FH Jr, Nelson RA et al. Sensorineural hearing loss associated with systemic lupus erythematosus Otolaryngol Head Neck Surg 1986 94: 197–204
Andonopoulos AP, Naxakis S, Goumas P, Lygatsikas C . Sensorineural hearing disorders in systemic lupus erythematosus: a controlled study Clin Exp Rheumatol 1995 13: 137–141
Sperling NM, Tehrani K, Liebling A, Ginzler E . Aural symptoms and hearing loss in patients with lupus Otolaryngol Head Neck Surg 1998 118: 762–765
Reiter D, Konkle D, Myers A et al. Middle ear immittance in rheumatoid arthritis Arch Otolaryngol 1980 106: 114–117
Elwany S, Garf A, Kamel T . Hearing and middle ear function in rheumatoid arthritis J Rheumatol 1986 13: 878–881
Magaro M, Zoli A, Altomonte L et al. Sensorineural hearing loss in rheumatoid arthritis Clin Exp Rheumatol 1990 8: 487–490
Kastanioudakis I, Skevas A, Danielidis V et al. Inner ear involvement in rheumatoid arthritis: a prospective clinical study J Laryngol Otol 1995 109: 713–718
Larry NS . Unilateral sensorineural hearing loss in Behçet’s disease Am J Otolaryngol 1994 15: 286–288
Igarashi Y, Watanabe Y, Aso S . A case of Behçet’s disease with otologic symptoms Otol Rhinol Laryngol 1994 56: 295–298
Cogan DG . Syndrome of nonsyphilitic interstitial keratitis and vestibuloauditory symptoms Arch Opthalmol 1945 33: 144–149
Norton EWD, Cogan DG . Syndrome of nonsyphilitic interstitial keratitis and vestibuloauditory symptoms Arch Opthalmol 1959 61: 695–700
Jacob A, Ledingham JG, Kerr AIG, Ford MJ . Ulcerative colitis and giant cell arteritis associated with sensorineural deafness J Laryngol Otol 1990 104: 889–890
Kumar BN, Walsh RM, Wilson PS, Carlin WV . Sensorineural hearing loss and ulcerative colitis J Laryngol Otol 1997 111: 277–278
Ruckenstein MJ, Mount RJ, Harrison RV . The MRL-lpr/lpr mouse: a potential model of autoimmune inner ear disease Acta Otolaryngol (Stockh) 1993 113: 160–165
Ruckenstein MJ, Hu L . Antibody deposition in the stria vascularis of the MRL-Faslpr mouse Hear Res 1999 127: 137–142
Ruckenstein MJ, Keithley EM, Bennett T et al. Ultrastructural pathology in the stria vascularis of the MRL-Faslpr mouse Hear Res 1999 131: 22–28
Kusakari C, Hozawa K, Koike S et al. MRL/Mp-lpr/lpr mouse as a model of immune-induced sensorineural hearing loss Ann Otol Rhinol Laryngol 1992 101: 82–86
Wobig RJ, Kempton JB, Trune DR . Steroid-responsive cochlear dysfunction in the MRL/lpr autoimmune mouse Otolaryngol Head Neck Surg 1999 121: 344–347
Iwai H, Tomoda K, Hosaka N et al. Induction of immune-mediated hearing loss in SCID mice by injection of MRL/lpr mouse spleen cells Hear Res 1998 117: 173–177
Ikehara S, Yasumizu R, Inaba M et al. Long-term observations of autoimmune-prone mice treated for autoimmune disease by allogeneic bone marrow transplantation Proc Natl Acad Sci USA 1989 86: 3306–3310
Yasumizu R, Sugiura K, Iwai H et al. Treatment of type 1 diabetes mellitus in non-obese diabetic mice by transplantation of allogeneic bone marrow and pancreatic tissue Proc Natl Acad Sci USA 1987 84: 6555–6557
Nishimura M, Toki J, Sugiura K et al. Focal segmental glomerular sclerosis, a type of intractable chronic glomerulonephritis, is a stem cell disorder J Exp Med 1994 179: 1053–1058
Ikehara S, Good RA, Nakamura T et al. Rationale for bone marrow transplantation in the treatment of autoimmune diseases Proc Natl Acad Sci USA 1985 82: 2483–2487
Kushida T, Inaba M, Takeuchi K et al. Treatment of intractable autoimmune diseases in MRL/lpr mice using a new strategy for allogeneic bone marrow transplantation Blood 2000 95: 1862–1868
Takeuchi K, Inaba M, Miyashima S et al. A new strategy for treatment of autoimmune diseases in chimeric resistant MRL/lpr mice Blood 1998 91: 4616–4623
Ishida T, Inaba M, Hisha H et al. Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation J Immunol 1994 152: 3119–3127
Hashimoto F, Sugiura K, Inoue K, Ikehara S . Major histocompatibility complex restriction between hematopoietic stem cells and stromal cells in vivo Blood 1997 89: 49–54
Takahashi M, Harris JP . Anatomic distribution and localization of immunocompetent cells in normal mouse endolymphatic sac Acta Otolaryngol (Stockh) 1988 106: 409–416
Theofilopoulos AN, Dixon FJ . Murine models of systemic lupus erythematosus Adv Immunol 1985 37: 269–290
Theofilopoulos AN, Kofler R, Singer PA, Dixon FJ . Molecular genetics of murine lupus models Adv Immunol 1989 46: 61–109
Peng SL, Craft J . The regulation of murine lupus Ann NY Acad Sci 1997 815: 128–138
Li H, Borg E . Age-related loss of auditory sensitivity in two mouse genotypes Acta Otolaryngol (Stockh) 1991 111: 827–834
Aldouri MA, Ruggier R, Epstein O, Prentice HG . Adoptive transfer of hyperthyroidism and autoimmune thyroiditis following allogeneic bone marrow transplantation for chronic myeloid leukaemia Br J Haematol 1990 74: 118–119
Wyatt DT, Lum L, Casper J et al. Autoimmune thyroiditis after bone marrow transplantation Bone Marrow Transplant 1990 5: 357–361
Kishimoto Y, Yamamoto Y, Ito T et al. Transfer of autoimmune thyroiditis and resolution of palmoplantar pustular psoriasis following allogeneic bone marrow transplantation Bone Marrow Transplant 1997 19: 1041–1043
Holland FJ, McConnon JK, Volpe R, Saunders EF . Concordant Graves’ disease after bone marrow transplantation: implication for pathogenesis J Clin Endocrinol Metab 1991 72: 837–840
Lampeter EF, Homberg M, Quabeck K et al. Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation Lancet 1993 341: 1243–1244
Vialettes B, Maraninchi D, San Marco MP et al. Autoimmune polyendocrine failure-type 1 (insulin-dependent) diabetes mellitus and hypothyroidism after allogeneic bone marrow transplantation in a patient with lymphoblastic leukaemia Diabetologia 1993 36: 541–546
Grau JM, Casademont J, Monforte R et al. Myasthenia gravis after allogeneic bone marrow transplantation: report of a new case and pathogenetic considerations Bone Marrow Transplant 1990 5: 435–437
Melms A, Faul C, Sommer N et al. Myasthenia gravis after BMT: identification of patients at risk? Bone Marrow Transplant 1992 9: 78–79
Liu Yin JA, Jowitt SN . Resolution of immune-mediated diseases following allogeneic bone marrow transplantation for leukaemia Bone Marrow Transplant 1992 9: 31–33
Eedy DJ, Burrows D, Bridges JM, Jones FG . Clearance of severe psoriasis after allogeneic bone marrow transplantation Br Med J 1990 300: 908–909
Ikehara S . Autoimmune diseases as stem cell disorders: normal stem cell transplant for their treatment Int J Mol Med 1998 1: 5–16
Acknowledgements
We thank Ms K Ando and Mr H Eastwick-Field for their help in the preparation of the manuscript. This work was supported by a grant application agency (grants-in-aid for scientific research 08671994 and 11671712 from the Ministry of Education, Science and Culture).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lee, S., Iwai, H., Sugiura, K. et al. Prevention of autoimmune hearing loss in MRL/lpr mice by bone marrow transplantation. Bone Marrow Transplant 26, 887–892 (2000). https://doi.org/10.1038/sj.bmt.1702636
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702636
Keywords
This article is cited by
-
Allogeneic yet major histocompatibility complex-matched bone marrow transplantation in mice results in an impairment of osteoblasts and a significantly reduced trabecular bone
Journal of Bone and Mineral Metabolism (2018)
-
Feasibility study of marrow stromal cells transplantation into guinea pig cochlea
Journal of Central South University of Technology (2005)
-
Prevention of accelerated presbycusis by bone marrow transplantation in senescence-accelerated mice
Bone Marrow Transplantation (2001)